1,190 results on '"Kaasa, S"'
Search Results
2. Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment
3. European Society for Medical Oncology (ESMO) position paper on supportive and palliative care
4. Which factors can aid clinicians to identify a risk of pain during the following month in patients with bone metastases? A longitudinal analyses
5. Reply to the Letter to the Editor “A simple way of doing the complex but utmost important things: cancer pain management” by S. Singhal, M. Verma and D. Kukreja
6. High Protein Oral Nutritional Supplements Enable The Majority Of Cancer Patients To Meet ESPEN Protein Recommendations During Systemic Treatment
7. Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series.
8. Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV ‘real life’ trial on the variability of response to opioids
9. Does chemotherapy improve health-related quality of life in advanced pancreatic cancer? A systematic review
10. The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06)
11. Depression in advanced cancer – Assessment challenges and associations with disease load
12. An international, open-label, randomised trial comparing a two-step approach versus the standard three-step approach of the WHO analgesic ladder in patients with cancer
13. An international, multicentre, open randomised parallel group trial comparing a two-step approach for pain relief versus the standard three-step approach of the WHO analgesic ladder in patients with cancer
14. 282MO Brain metastases: Real-life treatment patterns, survival and patient-reported outcomes – Results from a population-based, prospective study in 914 patients
15. 1272P Living with brain metastases: A longitudinal qualitative study of patient experiences from time of diagnosis
16. Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model—a study based on data from an international multicentre project (EPCRC-CSA)
17. Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force
18. Effect of physical exercise on muscle mass and strength in cancer patients during treatment—A systematic review
19. Who experiences higher and increasing breathlessness in advanced cancer? The longitudinal EPCCS Study
20. Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients
21. How to switch from morphine or oxycodone to methadone in cancer patients? A randomised clinical phase II trial
22. Influence from genetic variability on opioid use for cancer pain: A European genetic association study of 2294 cancer pain patients
23. Feasibility and acceptance of electronic monitoring of symptoms and syndromes using a handheld computer in patients with advanced cancer in daily oncology practice
24. Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV ‘real life’ trial on the variability of response to opioids
25. Reply to the letter to the editor ‘Integration between oncology and palliative care: does one size fit all?’ by Verna et al.
26. 373P Brain metastases: Extracranial disease status as a prognostic factor after whole brain radiotherapy. Results from a prospective, population-based study
27. 1441O Patient-reported outcomes in cancer patients newly diagnosed with brain metastases
28. Renal function and symptoms/adverse effects in opioid-treated patients with cancer
29. Indicators of integration of oncology and palliative care programs: an international consensus
30. The length of consent documents in oncological trials is doubled in twenty years
31. Classification algorithm for the International Classification of Diseases-11 chronic pain classification: development and results from a preliminary pilot evaluation
32. Genetic clustering of European cancer patients indicates that opioid-mediated pain relief is independent of ancestry
33. 1611P Family carers’ experiences with brain metastases: A longitudinal qualitative study
34. 1592MO Anticancer therapy at the end-of-life: A cluster-randomized trial
35. Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model—a study based on data from an international multicentre project (EPCRC-CSA)
36. Elderly gynaecological cancer patients at risk for poor end of life care : a population-based study from the Swedish Register of Palliative Care
37. Mild to Moderate Cognitive Impairment Does Not Affect the Ability to Self-Report Important Symptoms in Patients With Cancer: A Prospective Longitudinal Multinational Study (EPCCS).
38. Intention-to-Treat Analyses for Randomized Controlled Trials in Hospice/Palliative Care: The Case for Analyses to be of People Exposed to the Intervention
39. A prospective study of health-related quality of life, fatigue, anxiety and depression 3–5 years after stem cell transplantation
40. How to evaluate the effect of pain treatments in cancer patients: Results from a longitudinal outcomes and endpoint Italian cohort study
41. Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma: A nordic lymphoma group trial
42. Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine
43. MULTIPLE LOCI MODULATE OPIOID THERAPY RESPONSE FOR CANCER PAIN: PP123
44. Low-dose transdermal buprenorphine – long-term use and co-medication with other potentially addictive drugs
45. The course of anxiety and depression during the first year after allogeneic or autologous stem cell transplantation
46. Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year?
47. Assessing the consistency of psychometric properties of the HRQoL scales within the EORTC QLQ-C30 across populations by means of the Mokken Scaling Model
48. 518P Treatment outcome and prognostic factors after chemoradiotherapy for anal cancer
49. 1829P Are patient-reported symptoms and concerns affected by body mass index (BMI) and weight loss (WL) in patients with cancer cachexia?
50. Elderly gynaecological cancer patients at risk for poor end of life care: a population-based study from the Swedish Register of Palliative Care
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.